You are here

QT Vascular enrols first patients for Chocolate Touch study

Singapore

CATALIST-LISTED healthcare company QT Vascular has announced that it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic.

In a filing to the Singapore Exchange on

sentifi.com

Market voices on:

Powered by GET.comGetCom